Skip to main content

Advertisement

SpringerLink
Log in

Second Hepatectomy for Recurrent Colorectal Liver Metastasis: Analysis of Preoperative Prognostic Factors

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Second hepatectomy is a potentially curative treatment for patients with hepatic recurrence of colorectal cancer. However, there is still no consensus about the patient selection criteria for second hepatectomy under these circumstances, and the factors affecting prognosis after second hepatectomy remain uncertain.

Methods

Clinicopathologic data for 111 consecutive patients with colorectal liver metastasis who underwent second hepatectomy at a single institution between 1985 and 2004, and for whom complete clinicopathologic reports were available, were subjected to univariate and multivariate analyses.

Results

The morbidity and mortality rates were 14% and 0%, respectively, and the overall 5-year survival rate was 41%. Multivariate analysis revealed that synchronous resection for the first liver metastasis (hazard ratio, 1.8), more than three tumors at the second hepatectomy (1.9), and histopathological involvement of the hepatic vein and/or portal vein by the first liver metastasis (1.7) were independently associated with poor survival. We used these three risk factors to devise a preoperative model for predicting survival. The 5-year survival rates of patients without any risk factors, and with one, two, or three risk factors, were 62%, 38%, 19%, and 0%, respectively.

Conclusions

Second hepatectomy is beneficial for patients without any risk factors. Before second hepatectomy, chemotherapy should be considered for patients with any of these risk factors, especially with two or three factors, in the adjuvant or neoadjuvant setting to prolong survival. These results need to be confirmed and validated in another data set or future prospective trial according to the scoring scheme we outline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.

Similar content being viewed by others

References

  1. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19:59–71

    Article  PubMed  CAS  Google Scholar 

  2. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86:332–7

    Article  PubMed  CAS  Google Scholar 

  3. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231:487–99

    Article  PubMed  CAS  Google Scholar 

  4. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235:759–66

    Article  PubMed  Google Scholar 

  5. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 2003; 238:871–83; discussion 83–4

    Article  PubMed  Google Scholar 

  6. Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225:51–60

    Article  PubMed  CAS  Google Scholar 

  7. Moriya Y, Sugihara K, Hojo K, Makuuchi M. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. Eur J Surg Oncol 1991; 17:519–25

    PubMed  CAS  Google Scholar 

  8. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938–46

    PubMed  CAS  Google Scholar 

  9. Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994; 220:657–62

    Article  PubMed  CAS  Google Scholar 

  10. Nordlinger B, Vaillant JC, Guiguet M, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12:1491–6

    PubMed  CAS  Google Scholar 

  11. Que FG, Nagorney DM. Resection of “recurrent” colorectal metastases to the liver. Br J Surg 1994; 81:255–8

    PubMed  CAS  Google Scholar 

  12. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 1995; 117:296–304

    Article  PubMed  CAS  Google Scholar 

  13. Riesener KP, Kasperk R, Winkeltau G, Schumpelick V. Repeat resection of recurrent hepatic metastases—improvement in prognosis? Eur J Surg 1996; 162:709–15

    PubMed  CAS  Google Scholar 

  14. Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 1997; 4:125–30

    Article  PubMed  CAS  Google Scholar 

  15. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 1999; 178:275–81

    Article  PubMed  CAS  Google Scholar 

  16. Muratore A, Polastri R, Bouzari H, Vergara V, Ferrero A, Capussotti L. Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol 2001; 76:127–32

    Article  PubMed  CAS  Google Scholar 

  17. Suzuki S, Sakaguchi T, Yokoi Y, et al. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 2001; 129:421–8

    PubMed  CAS  Google Scholar 

  18. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002; 235:863–71

    Article  PubMed  Google Scholar 

  19. Takahashi S, Inoue K, Konishi M, Nakagouri T, Kinoshita T. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery 2003; 133:627–34

    Article  PubMed  Google Scholar 

  20. Tanaka K, Shimada H, Ohta M, et al. Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer. World J Surg 2004; 28:482–7

    Article  PubMed  Google Scholar 

  21. Sugawara G, Isogai M, Kaneoka Y, Suzuki M, Yamaguchi A. Repeat hepatectomy for recurrent colorectal metastases. Surg Today 2005; 35:282–9

    Article  PubMed  Google Scholar 

  22. Pessaux P, Lermite E, Brehant O, Tuech JJ, Lorimier G, Arnaud JP. Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol 2006; 93:1–7

    Article  PubMed  Google Scholar 

  23. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003; 46(10 suppl):S22–31

    PubMed  Google Scholar 

  24. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000; 321:531–5

    Article  PubMed  CAS  Google Scholar 

  25. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22:229–37

    Article  PubMed  CAS  Google Scholar 

  26. Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22:23–30

    Article  PubMed  CAS  Google Scholar 

  27. Okano K, Yamamoto J, Moriya Y, et al. Macroscopic intrabiliary growth of liver metastases from colorectal cancer. Surgery 1999; 126:829–34

    PubMed  CAS  Google Scholar 

  28. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341:2039–48

    Article  PubMed  CAS  Google Scholar 

  29. Kemeny M. Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer. Cancer J 2002; 8(suppl 1):S82–8

    PubMed  Google Scholar 

  30. Kemeny N, Eid A, Stockman J, et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 2005; 91:97–101

    Article  PubMed  CAS  Google Scholar 

  31. Maindrault-Goebel F, Louvet C, Andre T, et al. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Eur J Cancer 1999; 35:1338–42

    Article  PubMed  CAS  Google Scholar 

  32. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastasis. Ann Surg Oncol 2001; 8:347–53

    Article  PubMed  CAS  Google Scholar 

  33. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003; 90:963–9

    Article  PubMed  CAS  Google Scholar 

  34. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003; 7:109–15; discussion 16–7

    Article  PubMed  Google Scholar 

  35. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038–48

    Article  PubMed  CAS  Google Scholar 

  36. Nordlinger B, Sorbye H, Debois M, et al. Feasibility and risks of pre-operative chemotherapy (CT) with FOLFOX 4 and surgery for resectable colorectal cancer liver metastases (LM). Interim results of the EORTC Intergroup randomized phase III study 40983 (abstract). J Clin Oncol 2005; 23(16 suppl):3528

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Colorectal Surgery Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Seiji Ishiguro MD, Takayuki Akasu MD, Yoshiya Fujimoto MD, Seiichiro Yamamoto MD, Shin Fujita MD & Yoshihiro Moriya MD

  2. Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Junji Yamamoto MD, Yoshihiro Sakamoto MD, Tsuyoshi Sano MD, Kazuaki Shimada MD & Tomoo Kosuge MD

Authors
  1. Seiji Ishiguro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takayuki Akasu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiya Fujimoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junji Yamamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshihiro Sakamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tsuyoshi Sano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuaki Shimada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomoo Kosuge MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Seiichiro Yamamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shin Fujita MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoshihiro Moriya MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takayuki Akasu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishiguro, S., Akasu, T., Fujimoto, Y. et al. Second Hepatectomy for Recurrent Colorectal Liver Metastasis: Analysis of Preoperative Prognostic Factors. Ann Surg Oncol 13, 1579–1587 (2006). https://doi.org/10.1245/s10434-006-9067-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9067-z

Keywords

Search

Navigation